[
    {
        "title": "Eaton makes a move outside of the data center \u2014 plus, what's new with Abbott Labs",
        "date": "2025-06-16 21:12:55",
        "sentiment": "neutral",
        "explanation": "The title mentions Abbott Labs (ABT), but the description focuses on an \"actionable afternoon update\" from the Investing Club. There's no direct, quantifiable information or event related to ABT that would trigger immediate positive or negative price movement. The context is too broad and lacks the specificity to cause a significant reaction within the 60-minute timeframe.\n```"
    },
    {
        "title": "Abbott Laboratories declares $0.59 dividend | $ABT",
        "date": "2025-06-13 17:53:17",
        "sentiment": "neutral",
        "explanation": "A dividend declaration is generally expected and this news provides no immediate, surprising information that would significantly impact ABT's price within the next 60 minutes. The declaration itself is not a major catalyst and unlikely to trigger immediate buying or selling pressure from short-term algorithmic traders. Therefore, the impact is likely to be negligible in the very short term.\n```"
    },
    {
        "title": "Tandem, Abbott in deal to combine insulin delivery with glucose-ketone sensor",
        "date": "2025-06-10 15:36:25",
        "sentiment": "positive",
        "explanation": "A deal combining insulin delivery with a glucose-ketone sensor suggests potential for increased revenue and market share for ABT in the diabetes management space. The collaboration with Tandem represents a significant development and likely positive surprise for short-term traders. This collaboration news acting as a catalyst is likely to trigger immediate buying pressure due to perceived synergy and competitive advantage.\n```"
    },
    {
        "title": "An Abbott competitor drops out \u2014 plus, a special circumstance for Nvidia earnings",
        "date": "2025-05-28 20:41:49",
        "sentiment": "positive",
        "explanation": "The news mentions an Abbott competitor dropping out, which directly benefits ABT by potentially increasing its market share and sales in the short term. This constitutes a positive surprise as it reduces competition, and traders will likely react favorably, leading to an immediate price increase within the next 60 minutes.\n```"
    },
    {
        "title": "Texas signs into law online saftey bill reportedly opposed by Apple\u2019s Tim Cook",
        "date": "2025-05-27 22:11:26",
        "sentiment": "neutral",
        "explanation": "This news primarily concerns Apple and Google, with no discernible direct impact on ABT's revenue, costs, operations, or market share. The news is unlikely to trigger any immediate trading activity specifically related to ABT within the 60-minute timeframe, as there are no direct or indirect financial or operational implications for the company.\n```"
    },
    {
        "title": "Abbott gets FDA nod for Tendyne valve for mitral valve disease",
        "date": "2025-05-27 16:28:29",
        "sentiment": "positive",
        "explanation": "FDA approval is a significant positive catalyst for Abbott, indicating the product has passed regulatory hurdles and is ready for commercialization. This approval represents a direct positive impact, and is unexpected (as approvals are uncertain), leading to a sentiment trigger for immediate buying pressure in the short term as traders react to this news.\n```"
    },
    {
        "title": "2025 Could Be The Year Texas Ends Taxpayer-Funded Lobbying",
        "date": "2025-05-21 02:41:07",
        "sentiment": "neutral",
        "explanation": "This news about potential changes to taxpayer-funded lobbying in Texas has no direct or readily apparent impact on ABT's revenue, operations, or market share within the next 60 minutes. There's no quantifiable data or identifiable sentiment trigger directly affecting ABT, leading to a low likelihood of significant price deviation.\n```"
    },
    {
        "title": "Quinta Brunson isn't surprised by her success: 'I made every single move in my life so that this could happen to me'",
        "date": "2025-05-17 17:00:01",
        "sentiment": "neutral",
        "explanation": "This news is about the success of the show \"Abbott Elementary\" and its creator. While the show shares a name with Abbott Laboratories (ABT), the success of the show has no direct impact on ABT's revenue, costs, operations, or market share within the next 60 minutes. Therefore, it's unlikely to cause any price movement.\n```"
    },
    {
        "title": "X Advertisers From Nestle to Shell Deny Musk\u2019s Boycott Claims",
        "date": "2025-05-15 21:13:01",
        "sentiment": "neutral",
        "explanation": "The news discusses Abbott Laboratories denying involvement in an advertising boycott on X. This has no direct impact on ABT's financials, operations or immediate market share. The issue is tangential, not a significant surprise, and unlikely to trigger immediate buy or sell pressure within the next 60 minutes related directly to ABT's performance.\n```"
    },
    {
        "title": "MotoAmerica is Changing Concussion Safety",
        "date": "2025-05-15 16:59:42",
        "sentiment": "positive",
        "explanation": "The news highlights Abbott's rapid blood test being adopted by MotoAmerica, signaling increased visibility and potential adoption by other sports organizations. This news provides a positive, though likely small, revenue stream and enhances ABT's reputation, which may lead to immediate positive sentiment among traders in the next 60 minutes due to the association with safety and innovation.\n```"
    },
    {
        "title": "Texas Sweetens Pitch to CEOs, Boards With New State Protections",
        "date": "2025-05-14 17:24:50",
        "sentiment": "neutral",
        "explanation": "This news about Texas attracting companies from Delaware has no direct impact on ABT's financials, operations, or market share within the next 60 minutes. There is no identifiable catalyst or quantifiable data related to ABT, making any short-term price movement unlikely due to this news alone.\n```"
    },
    {
        "title": "SA analyst downgrades: QDEL, AMCX, PLYM, DAY | $QDEL $AMCX $PLYM $DAY $ABT",
        "date": "2025-05-13 17:29:35",
        "sentiment": "negative",
        "explanation": "While the analyst downgrade is part of a group, the mention of ABT in the title suggests it is also being downgraded. This negative analyst action is likely to trigger a short-term selling reaction from algorithmic and retail traders immediately after publication. The surprise element of a fresh downgrade within the next hour makes a short-term price decrease probable.\n```"
    },
    {
        "title": "Trump administration to review nutrients in baby formula | $ABT $PRGO $NSRGY $RBGLY $RBGPF",
        "date": "2025-05-13 16:50:06",
        "sentiment": "neutral",
        "explanation": "The news that the Trump administration will review nutrients in baby formula has limited immediate impact on ABT. While ABT may have some exposure to this market, the review itself doesn't guarantee any immediate change to sales, costs, or market share in the next 60 minutes. The news is more of a potential long-term concern and lacks the immediate surprise or quantifiable data needed for a significant short-term reaction.\n```"
    },
    {
        "title": "Abbott gains after upcoming baby formula case thrown out | $ABT $RBGPF",
        "date": "2025-05-02 22:14:30",
        "sentiment": "positive",
        "explanation": "The news of a case related to baby formula being thrown out is likely to be perceived positively by short-term traders. This suggests reduced legal risk and potential improvement in the public image regarding Abbott's baby formula business, which can trigger immediate buying pressure. This positive sentiment, though potentially short-lived, will likely drive the price upwards within the next 60 minutes due to immediate trader reactions.\n```"
    },
    {
        "title": "Texas Maps $1 Billion Voucher Plan as Schools Face Budget Crunch",
        "date": "2025-05-02 16:00:23",
        "sentiment": "neutral",
        "explanation": "This news pertains to education funding in Texas and has no direct, identifiable impact on ABT's revenue, costs, operations, or market share within the next 60 minutes. While broader state budget issues might indirectly affect various sectors in the long run, there is no immediate catalyst for a significant price deviation for ABT.\n```"
    },
    {
        "title": "Abbott signs agreement with Epic for CGM data integration",
        "date": "2025-04-29 18:26:01",
        "sentiment": "positive",
        "explanation": "This news is likely positive due to the integration of Abbott's CGM data with Epic's widely used electronic health record system. This signifies increased accessibility and utility of Abbott's products, potentially driving short-term trader interest and creating an immediate positive price reaction based on the \"catalyst check\" (partnership) and \"sentiment trigger\" (FOMO buying).\n```"
    },
    {
        "title": "Health Care Sector In 2025: Buy Abbott Labs",
        "date": "2025-04-28 12:00:00",
        "sentiment": "positive",
        "explanation": "The title suggests a buy recommendation specifically for Abbott Labs, and the description highlights its \"superior relative strength.\" This will likely trigger short-term buying pressure from algorithmic and retail traders based on positive sentiment within the next 60 minutes, as it is a readily digestible signal for potential gains. The specific mention of \"Abbott Labs\" makes this a direct positive catalyst.\n```"
    },
    {
        "title": "Medtronic seeks FDA nod for insulin pump developed with Abbott",
        "date": "2025-04-24 18:04:45",
        "sentiment": "negative",
        "explanation": "Medtronic, a competitor, seeking FDA approval for an insulin pump developed with Abbott suggests increased competition for ABT in that market. This news, while perhaps anticipated eventually, likely triggers short-term negative sentiment as traders reassess ABT's competitive position. Therefore, the news itself will likely push ABT's price down slightly in the next 60 minutes.\n```"
    },
    {
        "title": "The 13 best things to stream this weekend, from the season 1 finale of 'Daredevil: Born Again' to the horror-comedy 'Companion'",
        "date": "2025-04-18 18:08:01",
        "sentiment": "neutral",
        "explanation": "The news article is about streaming entertainment, specifically recommending shows and movies. There is no direct impact identified on ABT's financials, operations, or market share, and it is therefore unlikely to influence the stock price in the next 60 minutes.\n```"
    },
    {
        "title": "Abbott Labs shares surge on earnings and a big sign of confidence in the business",
        "date": "2025-04-16 19:30:05",
        "sentiment": "positive",
        "explanation": "The news indicates a strong earnings beat and reaffirmed guidance, signaling confidence in Abbott's business. This constitutes a positive surprise and a direct impact on ABT's financial outlook, likely triggering immediate buying pressure from short-term traders and driving the stock price up within the 60-minute timeframe.\n```"
    },
    {
        "title": "Abbott signals 2025 sales growth driven by medtech pipeline and margin expansion",
        "date": "2025-04-16 17:24:49",
        "sentiment": "positive",
        "explanation": "The news signals future sales growth and margin expansion, both positive indicators for investors. While focusing on 2025, the near-term sentiment trigger is likely positive as traders anticipate future profitability and growth based on the medtech pipeline, potentially driving immediate buying pressure.\n```"
    },
    {
        "title": "Abbott spikes as management addresses tariff concerns",
        "date": "2025-04-16 17:11:19",
        "sentiment": "positive",
        "explanation": "The title \"Abbott spikes as management addresses tariff concerns\" suggests a positive immediate reaction. The word \"spikes\" indicates an upward price movement already in motion. Addressing tariff concerns, even without details, is likely viewed positively by short-term traders as it reduces uncertainty, creating immediate buying pressure.\n```"
    },
    {
        "title": "Abbott Labs sees demand for diabetes products jump, and the stock surges",
        "date": "2025-04-16 16:01:00",
        "sentiment": "positive",
        "explanation": "The news clearly states \"Abbott Labs sees demand for diabetes products jump, and the stock surges\" and that ABT is leading the S&P 500 gainers. This is a direct, positive impact on revenue (diabetes products) and is coupled with immediate market reaction (\"stock surges\"), indicating significant surprise and likely short-term trader FOMO. The surge mentioned explicitly points to a high probability of continued upward price movement in the immediate future (next 60 minutes).\n```"
    },
    {
        "title": "4 stocks to watch on Wednesday: ABT, TRV, GOOGL/GOOG and HTZ | $GOOG $ABT $TRV $GOOGL $HTZ",
        "date": "2025-04-16 15:29:45",
        "sentiment": "neutral",
        "explanation": "The news title simply mentions ABT as one of several stocks to watch. There's no direct, quantifiable data or surprise factor regarding ABT's performance implied within this title. The lack of specific information regarding ABT suggests minimal immediate impact on its stock price within the next 60 minutes.\n```"
    },
    {
        "title": "Abbott Labs Profit Jumps on Gains in Nutrition, Medical Devices",
        "date": "2025-04-16 14:23:00",
        "sentiment": "positive",
        "explanation": "\"Profit Jumps\" suggests a positive surprise in earnings. The gains in nutrition and medical devices further signal strength in key business segments for ABT. This positive headline is likely to trigger immediate buying pressure from short-term traders, driving the price up in the next 60 minutes.\n```"
    },
    {
        "title": "Abbott slips after Q1 revenue miss; guidance reaffirmed | $ABT $JNJ",
        "date": "2025-04-16 14:15:41",
        "sentiment": "negative",
        "explanation": "The news title indicates that Abbott (ABT) missed its Q1 revenue expectations. Revenue misses are generally viewed negatively by the market, especially in the short term, as they directly impact profitability. While guidance was reaffirmed, the initial negative reaction to the revenue miss is likely to drive selling pressure in the next 60 minutes.\n```"
    },
    {
        "title": "Abbott Labs stock slips on Q1 sales miss",
        "date": "2025-04-16 13:58:00",
        "sentiment": "negative",
        "explanation": "\"Q1 sales miss\" is a direct, negative impact on ABT's financials. The news is likely unexpected by some traders, as it's explicitly stated to be a \"miss,\" leading to immediate selling pressure in the short term. This constitutes a key catalyst (earnings) underperforming expectations, triggering negative sentiment and price decline.\n```"
    },
    {
        "title": "Earnings Snapshot: Abbott Laboratories Q1 earnings beat; revenue misses estimate; reaffirms FY outlook",
        "date": "2025-04-16 13:44:42",
        "sentiment": "neutral",
        "explanation": "The news presents mixed signals: an earnings beat (positive) is counteracted by a revenue miss (negative) and a reaffirmation of the FY outlook (neutral). The immediate reaction will likely be ambiguous as traders weigh the components, resulting in no significant directional price movement within the next 60 minutes.\n```"
    },
    {
        "title": "Abbott in charts: Medical Devices sales up 10% Y/Y in Q1, down 3% sequentially",
        "date": "2025-04-16 13:40:25",
        "sentiment": "neutral",
        "explanation": "Medical device sales being up 10% Y/Y is positive, but down 3% sequentially raises concern. Mixed information like this typically creates uncertainty in the short term, making any strong directional price movement within 60 minutes unlikely due to conflicting interpretations. Therefore, a neutral classification is appropriate.\n```"
    },
    {
        "title": "Abbott to Expand US Manufacturing as Tariffs Loom",
        "date": "2025-04-16 13:34:46",
        "sentiment": "negative",
        "explanation": "The mention of potentially pulling infant formula for premature babies off the market and investor concerns about lawsuits introduce significant uncertainty and potential financial risk. This negative sentiment, coupled with the immediate focus on legal liabilities, will likely trigger selling pressure in the short term.\n```"
    },
    {
        "title": "Abbott Laboratories Non-GAAP EPS of $1.09 beats by $0.02, revenue of $10.36B misses by $60M",
        "date": "2025-04-16 13:31:24",
        "sentiment": "neutral",
        "explanation": "While the EPS beat is positive, the revenue miss offsets it within a short timeframe. Traders are likely to see this as a mixed report and may not react strongly in either direction in the immediate 60 minutes. The conflicting data points create ambiguity, reducing the likelihood of a significant directional price movement triggered solely by this news.\n```"
    },
    {
        "title": "Abbott's Q1 earnings in focus as analysts see path to beat amid business strength",
        "date": "2025-04-15 18:27:14",
        "sentiment": "positive",
        "explanation": "The title mentions \"analysts see path to beat amid business strength,\" suggesting positive Q1 earnings expectations. While the actual earnings aren't released yet, this positive anticipation could create short-term buying pressure and increase the stock price in the next 60 minutes, especially given the mention of \"business strength.\" This anticipated beat acts as a sentiment trigger for short-term traders.\n```"
    },
    {
        "title": "\u2018WrestleMania 41,\u2019 Plus 8 Things to Watch on TV this Week",
        "date": "2025-04-14 07:00:07",
        "sentiment": "neutral",
        "explanation": "The news item is about television programming and only mentions \"Abbott Elementary\" concluding its fourth season. This has no direct impact on ABT's financials, operations, or market share, and therefore should not cause any significant price movement in the immediate 60-minute timeframe.\n```"
    },
    {
        "title": "Beyond Paradise is taking a 'grittier' turn",
        "date": "2025-04-11 10:02:32",
        "sentiment": "neutral",
        "explanation": "Sentiment: [**NEUTRAL**] Explanation: [This news item about a television show has no direct impact on ABT's revenue, costs, operations, or market share. There's no catalyst or any quantifiable data related to Abbott. Therefore, there is no reason to believe this will cause any price deviation within the next 60 minutes.] ```"
    },
    {
        "title": "Stryker, Boston Scientific down as new tariffs impact medtech industry | $JNJ $ABT $BSX $MDT $SYK",
        "date": "2025-04-03 18:42:10",
        "sentiment": "negative",
        "explanation": "The news of new tariffs impacting the medtech industry, specifically mentioning ABT alongside competitors like Stryker, Boston Scientific, JNJ, MDT, and SYK, suggests a potential increase in costs and a negative impact on profit margins for the sector as a whole. The immediate sentiment trigger is likely to be negative as traders react to the potential for reduced profitability in the short term due to increased import/export costs.\n```"
    },
    {
        "title": "Trump unlikely to specify any pharma tariffs in \u2018Liberation Day\u2019 announcement: Reuters | $JNJ $ABT $PFE $MRK $AMGN",
        "date": "2025-04-01 13:13:37",
        "sentiment": "positive",
        "explanation": "The news suggests that potential negative catalysts (pharma tariffs) are less likely to occur, which is a positive surprise. Within the next 60 minutes, traders will likely react favorably to the reduced risk of tariffs negatively impacting ABT's revenue and profitability, causing a slight price increase.\n```"
    },
    {
        "title": "Abbott Delays Calling a Special House Election. Democrats Cry Foul.",
        "date": "2025-03-31 23:25:53",
        "sentiment": "neutral",
        "explanation": "The news pertains to a political issue in Texas and has no discernible direct impact on Abbott's (ABT) revenue, costs, operations, or market share within the next 60 minutes. While political events can sometimes indirectly affect businesses, this particular item is too far removed from ABT's core business to trigger any immediate, significant trading activity.\n```"
    },
    {
        "title": "Abbott gets FDA approval to begin trial of intravascular lithotripsy device",
        "date": "2025-03-24 14:58:27",
        "sentiment": "positive",
        "explanation": "FDA approval for a trial is a positive catalyst, especially for a medical device company like ABT. This news suggests potential future revenue streams and positive market sentiment, likely leading to a short-term price increase due to traders anticipating successful trial outcomes and eventual product commercialization.\n```"
    },
    {
        "title": "J.B. Moore, Producer of Seminal Hip-Hop Records, Dies at 81",
        "date": "2025-03-20 19:34:06",
        "sentiment": "neutral",
        "explanation": "This news item has no direct impact on ABT's revenue, costs, operations, or market share. It concerns the death of a music producer and is completely unrelated to the healthcare industry. Therefore, it is unlikely to trigger any significant price movement in ABT within the next 60 minutes.\n```"
    },
    {
        "title": "HHS to review nutrients, test for heavy metals in infant formula | $ABT $RBGPF $RBGLY",
        "date": "2025-03-18 17:30:20",
        "sentiment": "negative",
        "explanation": "The news regarding HHS review and testing for heavy metals in infant formula presents a potential negative catalyst for ABT given their involvement in the industry. While not explicitly stating ABT is a target, the association and potential for negative findings in testing introduces uncertainty and potential legal/financial repercussions within the next 60 minutes, likely triggering a negative market reaction.\n```"
    },
    {
        "title": "He sold Deliverr to Shopify for $2.1 billion. Now his new startup is betting big on an AI assistant named Augie.",
        "date": "2025-03-18 10:00:02",
        "sentiment": "neutral",
        "explanation": "This news about a former Shopify VP launching an AI startup in logistics has no direct impact on Abbott's revenue, costs, or operations. While the AI theme is currently popular, the news is about a separate company in a different sector and has no immediate implications for ABT's financial performance or competitive landscape in the next 60 minutes.\n```"
    },
    {
        "title": "Nearly a third of FDA medical device adverse events reported late: study | $ABT $MDT $BDX $DXCM $XRAY",
        "date": "2025-03-15 20:22:00",
        "sentiment": "negative",
        "explanation": "The news highlights a problem with medical device adverse event reporting, and while it names multiple companies, ABT is explicitly mentioned ($ABT). This association, even if not directly ABT specific, could create negative sentiment within the next 60 minutes, triggering a short-term sell-off as traders react to the headline. There is also a non-zero risk that investors will negatively evaluate ABT's role in reporting adverse events.\n```"
    },
    {
        "title": "Judge orders retrial in Abbott, Reckitt infant formula case | $ABT $RBGPF $RBGLY",
        "date": "2025-03-14 16:03:26",
        "sentiment": "negative",
        "explanation": "A judge ordering a retrial in an infant formula case involving Abbott directly impacts ABT's legal liabilities and potentially its revenue and reputation. This is a negative surprise, as it suggests ongoing legal challenges and uncertainties, which could trigger immediate selling pressure from short-term traders reacting negatively to increased risk within the next 60 minutes.\n```"
    },
    {
        "title": "Abbott, Reckitt Fall as Judge Grants New Trial on Infant Formula",
        "date": "2025-03-14 15:57:16",
        "sentiment": "negative",
        "explanation": "The news of a new trial and the failure to clear liability on infant formula claims is a negative catalyst. Even if the company ultimately prevails, the immediate reaction will likely be negative due to increased uncertainty and potential legal costs. This creates a high probability of short-term selling pressure in the next 60 minutes.\n```"
    },
    {
        "title": "Abbott, Apple, Citi, Nexstar, Musk, OpenAI: Votes and Verdicts",
        "date": "2025-03-05 16:42:41",
        "sentiment": "negative",
        "explanation": "The news mentions a March 24 hearing to bar experts in suits alleging Abbott infant formula caused necrotizing enterocolitis. This suggests ongoing legal challenges and potential liability for Abbott, which is a negative sentiment trigger and could cause short-term price decline in the next 60 minutes. The potential negative impact from litigation is a direct concern for short-term traders.\n```"
    }
]